Show simple item record

dc.creatorKolata, Ginaen
dc.creatorPollack, Andrewen
dc.date.accessioned2016-01-08T23:11:39Zen
dc.date.available2016-01-08T23:11:39Zen
dc.date.created2008-07-06en
dc.date.issued2008-07-06en
dc.identifier.bibliographicCitationNew York Times 2008 July 6; p. A1, A16, A17en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=In+costly+cancer+drug,+hope+and+a+dilemma:+some+pay+up+to+$100,000+a+year+for+Avastin's+arguable+benefits&title=New+York+Times&date=2008-07&au=Kolata,+Gina;+Pollack,+Andrewen
dc.identifier.urihttp://hdl.handle.net/10822/956184en
dc.formatNews Articleen
dc.languageenen
dc.sourceeweb:317848en
dc.subjectCanceren
dc.subject.classificationSocial Control of Science and Technologyen
dc.subject.classificationAllocation of Health Care Resourcesen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationEconomics of Health Careen
dc.subject.classificationHealth Care for Particular Diseases or Groupsen
dc.titleIn Costly Cancer Drug, Hope and a Dilemma: Some Pay Up to $100,000 a Year for Avastin's Arguable Benefitsen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2023 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885